SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0000950103-19-009212
Filing Date
2019-07-08
Accepted
2019-07-08 08:20:10
Documents
3
Group Members
022019 MERGER SUBSIDIARY, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-T/A dp109614_sctota8.htm SC TO-T/A 53598
2 EXHIBIT (A)(5)(XXII) dp109614_ex-a5xxii.htm EX-99.(A)(5)(XXII) 5691
3 EXHIBIT (D)(3) dp109614_ex-d3.htm EX-99.(D)(3) 18624
  Complete submission text file 0000950103-19-009212.txt   79588
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 0000

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88577 | Film No.: 19944255
SIC: 2836 Biological Products, (No Diagnostic Substances)